reference/9470810

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9470810

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2045-3701
issueIdentifier	1
pageRange	30-
publicationName	Cell & Bioscience
startingPage	30
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3da5d5672f7fa276ad729c4704fe280d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_07bea0375836b42642b357413a763117
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_497b3797ae98d7d6bc938e14dcb1067b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3adc741fe97c9dcebc91f5575a99e788 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6235d68fc4733bba08f49101c498929a
bibliographicCitation	Tang F, Du X, Liu M, Zheng P, Liu Y. Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? Cell & Bioscience. 2018 Apr 18;8(1):30. doi: 10.1186/s13578-018-0229-z.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_349a206574a457659dbc5113dd4cc714 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1475-5028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2598-3544 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb86588a2f87823a501319621dcd0a04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07c9fb52872a99c7416986d2abde906f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53433e4201e16ed6061bca0c85f95663
date	2018-04-18^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5907314 https://doi.org/10.1186/s13578-018-0229-z https://pubmed.ncbi.nlm.nih.gov/29713453
isPartOf	https://portal.issn.org/resource/ISSN/2045-3701 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39222
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3180f3560c702ffddc361716fecd9861 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3ad2119464233024868ba3753ac34390

Showing number of triples: 1 to 37 of 37.